Poly Medicure Limited Share Price and Company Fundamentals



Price
₹743.35
Change
2.250 (0.304%)
52 week
651.1 - 1094.25

Last traded: Today at 3:52 AM

Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.

Key Metrics

PE ratio

48.50

PB ratio

6.53

Dividend yield

0.34%

Beta

0.36

Market cap

-

Enterprise value

-

Company profile

Industry / SectorMedical Instruments & Supplies / Healthcare
Websitehttps://www.polymedicure.com
Mailing address232B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India
Phone / Fax91 11 2632 1838 / 91 11 2632 1839

Dividends

Dividend yield

0.34%

Dividend amount

₹2.50

Payout ratio

16.37%

Poly Medicure Limited paid ₹2.50 dividend and the ex-dividend date was 16 Sept 2021.The dividend payout ratio is 16.37%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.POLYMED dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

POLYMED's forward dividend amount is ₹2.5 and the forward dividend yield is 0.34%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Poly Medicure Limited.

NameTitleAgeTotal Pay
Mr. Himanshu BaidCEO, MD & Director5391.69M
Mr. Naresh VijayvergiyaChief Financial Officer54
Mr. Avinash ChandraCompany Sec. & Compliance Officer
Mr. Hemant Bhalla B.Sc.VP of Sales & Marketing62
Mr. Rishi BaidJoint MD & Exec. Director4989.6M
Mr. Vishal Baid C.A.Pres of Corp. Sales & Marketing47
Mr. Manish SardanaPres of Sales & Marketing - India49
Mr. P. K. RastogiAssistant VP of Fin. & Accounts50

Profitability and management effectiveness

Profit margin

15.87%

Operating margin

17.24%

Return on assets

7.65%

Return on equity

14.27%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Poly Medicure Limited is and its enterprise value is .

The POLYMED's stocks Beta value is 0.36 making it 64% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Poly Medicure Limited (NSE:POLYMED) Frequently Asked Questions

1. What is Poly Medicure Limited's Stock Symbol?

Poly Medicure Limited trades on NSE under the ticker symbol "POLYMED".

2. What is Poly Medicure Limited's stock price today?

One share of POLYMED stock can currently be purchased for approximately ₹743.35.

3. How can I contact Poly Medicure Limited?

Poly Medicure Limited's mailing address is 232B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India. The company can be reached via phone at 91 11 2632 1838.

4. What is Poly Medicure Limited's official website?

The official website of Poly Medicure Limited is https://www.polymedicure.com.